Wall Street brokerages expect Select Medical Holdings Co. (NYSE:SEM) to post sales of $1.10 billion for the current fiscal quarter, Zacks reports. Two analysts have made estimates for Select Medical’s earnings. Select Medical reported sales of $1.05 billion during the same quarter last year, which indicates a positive year-over-year growth rate of 4.8%. The firm is expected to report its next quarterly earnings results on Thursday, February 22nd.

According to Zacks, analysts expect that Select Medical will report full-year sales of $1.10 billion for the current year. For the next year, analysts anticipate that the company will post sales of $4.93 billion per share, with estimates ranging from $4.73 billion to $5.12 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that cover Select Medical.

Select Medical (NYSE:SEM) last released its quarterly earnings results on Thursday, November 2nd. The health services provider reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.02). Select Medical had a return on equity of 11.44% and a net margin of 2.21%. The firm had revenue of $1.10 billion for the quarter, compared to analysts’ expectations of $1.10 billion. During the same quarter last year, the firm posted $0.06 earnings per share. The firm’s revenue for the quarter was up 4.1% compared to the same quarter last year.

SEM has been the topic of several research reports. Zacks Investment Research lowered shares of Select Medical from a “hold” rating to a “sell” rating in a research report on Wednesday, December 13th. Robert W. Baird set a $25.00 price target on shares of Select Medical and gave the stock a “buy” rating in a report on Monday, October 23rd. Deutsche Bank reissued a “buy” rating and issued a $22.00 price target on shares of Select Medical in a report on Monday, November 6th. Royal Bank of Canada reaffirmed a “buy” rating and issued a $19.00 price objective on shares of Select Medical in a research note on Friday, October 13th. Finally, ValuEngine cut shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, October 2nd. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and five have assigned a buy rating to the company. Select Medical has an average rating of “Hold” and a consensus price target of $19.43.

In related news, insider Michael E. Tarvin sold 18,500 shares of the business’s stock in a transaction on Monday, October 30th. The shares were sold at an average price of $18.97, for a total value of $350,945.00. Following the sale, the insider now owns 340,044 shares in the company, valued at $6,450,634.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Martin F. Jackson sold 156,603 shares of the business’s stock in a transaction on Wednesday, December 13th. The stock was sold at an average price of $17.06, for a total transaction of $2,671,647.18. Following the completion of the sale, the insider now owns 1,790,601 shares in the company, valued at approximately $30,547,653.06. The disclosure for this sale can be found here. Insiders have sold 314,455 shares of company stock worth $5,403,144 in the last ninety days. Insiders own 19.93% of the company’s stock.

Several institutional investors and hedge funds have recently modified their holdings of the company. Amalgamated Bank boosted its stake in shares of Select Medical by 2.6% during the second quarter. Amalgamated Bank now owns 14,806 shares of the health services provider’s stock valued at $227,000 after purchasing an additional 376 shares during the period. PNC Financial Services Group Inc. lifted its stake in Select Medical by 4.8% in the second quarter. PNC Financial Services Group Inc. now owns 8,709 shares of the health services provider’s stock worth $133,000 after acquiring an additional 396 shares during the period. Public Employees Retirement System of Ohio lifted its stake in Select Medical by 1.0% in the second quarter. Public Employees Retirement System of Ohio now owns 50,364 shares of the health services provider’s stock worth $773,000 after acquiring an additional 487 shares during the period. The Manufacturers Life Insurance Company lifted its stake in Select Medical by 0.7% in the second quarter. The Manufacturers Life Insurance Company now owns 83,940 shares of the health services provider’s stock worth $1,288,000 after acquiring an additional 603 shares during the period. Finally, Alliancebernstein L.P. lifted its stake in Select Medical by 0.4% in the second quarter. Alliancebernstein L.P. now owns 158,688 shares of the health services provider’s stock worth $2,436,000 after acquiring an additional 700 shares during the period. 77.89% of the stock is owned by hedge funds and other institutional investors.

Select Medical (NYSE:SEM) traded up $0.25 on Friday, reaching $18.00. 312,907 shares of the company’s stock were exchanged, compared to its average volume of 711,092. Select Medical has a 52-week low of $12.00 and a 52-week high of $19.77. The company has a current ratio of 1.51, a quick ratio of 1.51 and a debt-to-equity ratio of 3.36. The stock has a market capitalization of $2,408.85, a PE ratio of 22.78, a price-to-earnings-growth ratio of 1.14 and a beta of 1.34.

WARNING: “$1.10 Billion in Sales Expected for Select Medical Holdings Co. (SEM) This Quarter” was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another site, it was illegally copied and reposted in violation of United States & international copyright legislation. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2018/01/14/1-10-billion-in-sales-expected-for-select-medical-holdings-co-sem-this-quarter.html.

Select Medical Company Profile

Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.

Get a free copy of the Zacks research report on Select Medical (SEM)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.